Pregnancy

Proov Launches New hCG Tests for Early Pregnancy Detection

Proov, known for its PdG-test and full cycle tracking kit is launching another product: The Proov Check Early Pregnancy Test. The new test allows women to use the tests up to five days before their next expected period to detect hCG (human Chorionic Gonadotropin) in urine, which is only present when pregnant. Results can be expected within 5 minutes of taking the…

Biotech Company Mirvie Raises $60M for Its RNA Platform Focused on Early Prediction of Pregnancy Complications

Mirvie‘s proprietary RNA platform combines revolutionary analysis of tens of thousands of RNA messages from the baby, the placenta and the mom, with machine learning. The platform opens a new window into pregnancy health for expecting parents to act and their doctors to intervene before unexpected complications become a crisis. It can predict preeclampsia and preterm birth months before they happen by…

Natural Cycles Adds New Features to Support Women after Pregnancy Loss

Natural Cycles, the FDA-cleared birth control app is introducing ‘Recovery Mode’ to support users who experience pregnancy loss before 20 weeks. The new feature was developed to help women who used its NC° Plan Pregnancy to conceive and whose pregnancy results in miscarriage as they recover physically and emotionally. About one in four pregnancies end in a miscarriage – a rate consistent with…

Ruth Health Raises $2.4M in Seed Funding to Reimagine Prenatal and Postpartum Care

Last year Los-Angeles based maternal health company Ruth Health went through Y-Combinator and UnitedHealthcare Accelerator Powered by Techstars. Today, as the company is preparing for further growth, they are announcing a $2.4M seed round led by Giant Ventures. Other participants in the round include Citylight VC, Cleo Capital Scout Fund, Crista Galli Ventures, Duro VC, Emmeline Ventures, Gaingels, Global Founders Capital, Pentas…

Australian Baymatob Raises $3M for Oli, Its AI-Guided PPH Monitoring Device

Australia-based Baymatob has raised AS4.215 ($3M) to continue clinical trials for its AI-guided labor monitoring device, Oli, that can predict postpartum hemorrhage, a leading cause of maternal death. The round was led by Australian Unity’s future of Healthcare Fund and supported by other institutional and high net worth investors. Bamyatob was founded in 2013 by Dr. Sarah McDonald after her own traumatic…

Renegade.bio and Metabolomic Diagnostics Partner to Develop a Novel Preeclampsia Risk Screening Test

Biotech firm Renegade.bio and Metabolomic Diagnostics are teaming up to develop a novel pre-eclampsia risk screening test, with plans to launch in the U.S. in late 2022. The test will be jointly developed specifically for the U.S. population, improving upon available assessments by creating a personalized risk profile for individuals. It measures a panel of biomarkers in blood that serves as early…

New Study Published in AJOG Suggests a Connection between COVID Infection During Pregnancy and Preterm Delivery

A new study on the effect of the COVID-19 virus in pregnancy has been published in the American Journal of Obstetrics and Gynecology. Analyzing data from 42754 pregnant women infected with the COVID-19 virus during pregnancy, the results of this systematic review and meta-analysis suggest a “strong connection between COVID infection and preterm delivery as well as an increased risk of cesarian…

Mitera Launches Two New At-Home Genetic Tests for Pregnancy to Screen for Conditions Like Down Syndrome

Mitera, a Mountain View-based company that provides telehealth services to address preganancy-related risks, has launched two new services today. 23Pears, an at-home expanded carrier screening test (ECS) that screens for 421 genes, and Peaches&Me, the the first at-home non-invasive prenatal test (NIPT), are now available throughout the U.S. Expanded carrier screening (which 23Pears offers) allows parents-to-be to examine their DNA and find…